Flurbiprofen (Ansaid, Ocufen)

Category:

  • Analgesic

Description:

  • NSAID, non-narcotic analgesic

Indications:

  • Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis

  • Inhibition of inoperative miosis (ophth), cystoid macular edema (non-FDA approved)

  • Inflammation after cataract or glaucoma laser surgery or uveitis syndromes (ophth: non-FDA approved)

  • Bursitis, primary dysmenorrhea, tendinitis, acute gout (all non-FDA approved)

Contraindications:

  • Dendritic keratitis (ophth)

Precautions:

  • Pregnancy category C; excreted in breast milk; use caution in nursing mothers

  • Bleeding tendencies, peptic ulcer

  • Hepatic/renal function impairment, elderly, CHF, hypertension

Adverse Reactions (Side Effects):

  • CNS: dizziness, headache, lightheadedness

  • CV: chest pain, CHF, dysrhythmias, edema, hyper/hypotension, palpitation, tachycardia

  • EENT: burning or stinging upon instillation, dry eyes, hearing disturbances, photophobia, tinnitus, visual disturbances

  • GI: abdominal cramps, constipation, diarrhea, dyspepsia, flatulence, gastric or duodenal ulcer with bleeding or perforation, hepatitis, nausea, occult blood in stool, pancreatitis, vomiting

  • GU: renal failure

  • HEME: agranulocytosis, eosinophilia, leukopenia, pancytopenia, thrombocytopenia

  • METAB: hyperglycemia, hyperkalemia, hypoglycemia, hyponatremia,

  • RESP: bronchospasm, dyspnea

  • SKIN: photosensitivity, rash, urticaria

Dosage:

  • Administered orally and ophthalmic instillation

  • Adult:            

    • Rheumatoid and osteoarthritis: PO 200-300mg daily divided 2-4 times daily

    • Dysmenorrhea: PO 50mg daily

    • Inhibition of intraoperative miosis: OPHTH 1 drop every 30 minutes beginning 2 hours before surgery (total 4 drops)

Drug interactions:

  • Warfarin: addition of flurbiprofen associated with excessive hypoprothrombinemia and bleeding; ibuprofen less likely to interact

  • Methotrexate: addition of flurbiprofen may interfere with the renal secretion of methotrexate, yielding increased risk of methotrexate toxicity

  • Prednisone: increase risk of GI ulceration

  • Loop diuretics: reduction in diuretic and antihypertensive effects

 

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site